BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3395Biotechnology
$15.10 −$0.48 (-3.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.10 0.00%
Open$15.40
Prev close$15.58
Day range$14.80 – $15.46
Volume372.2K
Market cap$690.26M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$41.00+171.5% vs. price
  • Buy 100%
Low $34.00Now $15.10Avg $41.00High $45.00

Recent rating changes

The last 13 actions on file set price targets from $30.00 to $45.00, averaging $39.38.

DateFirmRatingTarget
10 Nov 2026 Morgan Stanley BUY $40.00
10 Nov 2026 Citi BUY $34.00
9 Nov 2026 RBC Capital BUY $45.00
13 Oct 2026 Citi BUY $30.00
5 Sep 2026 LifeSci Capital BUY $45.00
3 Sep 2026 LifeSci Capital BUY $45.00
3 Sep 2026 Morgan Stanley BUY $39.00
3 Sep 2026 Citi BUY $30.00
2 Sep 2026 RBC Capital BUY $45.00
31 Aug 2026 LifeSci Capital BUY $45.00
31 Aug 2026 Morgan Stanley BUY $39.00
31 Aug 2026 Citi BUY $30.00
30 Aug 2026 RBC Capital BUY $45.00

Discussion

No comments yet — be the first to weigh in on ATTO.

Sign in to join the discussion.

Scroll to Top